SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11919132
Source:
http://linkedlifedata.com/resource/pubmed/id/11919132
Search
Subject
(
69
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0011854
,
umls-concept:C0021641
,
umls-concept:C0034656
,
umls-concept:C0087111
,
umls-concept:C0231448
,
umls-concept:C0443252
,
umls-concept:C0537551
,
umls-concept:C2603343
pubmed:issue
4
pubmed:dateCreated
2002-3-28
pubmed:abstractText
To assess the effect of mealtime amylin replacement with pramlintide on long-term glycemic and weight control in patients with type 1 diabetes.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11919132-12685439
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7805975
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Amyloid
,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated
,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin
,
http://linkedlifedata.com/resource/pubmed/chemical/Islet Amyloid Polypeptide
,
http://linkedlifedata.com/resource/pubmed/chemical/Placebos
,
http://linkedlifedata.com/resource/pubmed/chemical/pramlintide
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0149-5992
pubmed:author
pubmed-author:FinemanMarkM
,
pubmed-author:KoltermanOrville GOG
,
pubmed-author:KrugerDavida FDF
,
pubmed-author:MaggsDavid GDG
,
pubmed-author:RugglesJames AJA
,
pubmed-author:ShenLarryL
,
pubmed-author:WeyerChristianC
,
pubmed-author:WhitehouseFredF
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
724-30
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:11919132-Adolescent
,
pubmed-meshheading:11919132-Adult
,
pubmed-meshheading:11919132-Aged
,
pubmed-meshheading:11919132-Amyloid
,
pubmed-meshheading:11919132-Body Weight
,
pubmed-meshheading:11919132-Diabetes Mellitus, Type 1
,
pubmed-meshheading:11919132-Dose-Response Relationship, Drug
,
pubmed-meshheading:11919132-Double-Blind Method
,
pubmed-meshheading:11919132-Drug Therapy, Combination
,
pubmed-meshheading:11919132-Female
,
pubmed-meshheading:11919132-Hemoglobin A, Glycosylated
,
pubmed-meshheading:11919132-Humans
,
pubmed-meshheading:11919132-Hypoglycemia
,
pubmed-meshheading:11919132-Hypoglycemic Agents
,
pubmed-meshheading:11919132-Incidence
,
pubmed-meshheading:11919132-Insulin
,
pubmed-meshheading:11919132-Islet Amyloid Polypeptide
,
pubmed-meshheading:11919132-Male
,
pubmed-meshheading:11919132-Middle Aged
,
pubmed-meshheading:11919132-Patient Compliance
,
pubmed-meshheading:11919132-Placebos
pubmed:year
2002
pubmed:articleTitle
A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes.
pubmed:affiliation
Henry Ford Hospital, Detroit, Michigan, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Multicenter Study